Story perspectives

Genus GNS Shares Surge 29% Amid Record Profits

9/5/2025

48 9

Summary

Story summary

Genus GNS, a British animal genetics firm, experienced a 29% share increase after a 38% rise in annual adjusted pretax profit.
The company anticipates profit growth for fiscal year 2026, aligning with market expectations.
Record free cash flow and a joint venture in China boosted shares by 10% to £27.45.
Although full-year revenue fell slightly short of estimates, adjusted pre-tax profit surpassed forecasts.
The pig genetics division's success enhanced profitability in the bovine division, with plans to commercialize PRRS-resistant pig technology in China.

1 of 1

Story summary

Genus GNS, a British animal genetics firm, experienced a 29% share increase after a 38% rise in annual adjusted pretax profit.
The company anticipates profit growth for fiscal year 2026, aligning with market expectations.
Record free cash flow and a joint venture in China boosted shares by 10% to £27.45.
Although full-year revenue fell slightly short of estimates, adjusted pre-tax profit surpassed forecasts.
The pig genetics division's success enhanced profitability in the bovine division, with plans to commercialize PRRS-resistant pig technology in China.